We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Prof
Kimme
Hyrich
kimme.hyrich@manchester.ac.uk
Dr
Kath
Watson
biologics.register@manchester.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Inflammatory polyarthropathies
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK, to monitor the long-term safety of these drugs.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
Biologic naive if entering the anti-TNF comparison cohort (Humira, Enbrel, Remicade).
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Kath
Watson
biologics.register@manchester.ac.uk
Prof
Kimme
Hyrich
kimme.hyrich@manchester.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Manchester and funded by British Society for Rheumatology (BSR) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 7302
You can print or share the study information with your GP/healthcare provider or contact the research team directly.